Fort Myers-based cancer testing and research lab NeoGenomics expects to report double-digit revenue growth for 2025. However, ...

NeoGenomics ( (NEO)) has shared an announcement. On December 23, 2025, NeoGenomics’ board accepted the resignation of long-serving director Dr. Alison L. Hannah, effective December 31, 2025, and ...

Final arguments have been filed in the Compass-Zillow lawsuit over listing access. The court’s decision on the preliminary injunction is expected in the coming months. AI Summary Compass and Zillow ...

FORT MYERS, Fla. (AP) — FORT MYERS, Fla. (AP) — NeoGenomics Inc. (NEO) on Tuesday reported a loss of $27.1 million in its third quarter. On a per-share basis, the Fort Myers, Florida-based company ...

Compass Inc. stock (NYSE: COMP) has been experiencing significant pressure, having declined over 15% within the last week, while the S&P 500 only fell by 0.6%. The catalyst for this decline: Compass’s ...

The proposed merger with Anywhere Real Estate would create a nationwide real estate behemoth. By Rukmini Callimachi In a merger that would bring together the largest and second-largest real estate ...

Throughout its cycle, NEO has aligned closely with the Adhishthana Principles, our proprietary model that blends behavioral archetypes with quantitative signals. One of the best examples of this was ...

Hi. My name is Yuko Oku, and I'm on the life science tools and diagnostics team here at Morgan Stanley. For important disclosures, please see Morgan Stanley research ...

NeoGenomics said a federal court ruled in its favor in a patent dispute with Natera, clearing the way for the cancer-testing company to continue commercializing its RaDaR ST assay. The U.S. District ...

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the District Court for the Middle District of North Carolina has ...

NeoGenomics, Inc. (NASDAQ:NEO) is one of the top 10 medical AI companies to buy according to analysts. On July 30, the company announced the launch of NEO PanTracer LBx, a blood-based comprehensive ...